Introduction
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Major mood disorders are leading contributors to disease-17 burden due to their high prevalence and risks of recurrences, 18 sustained morbidity, and mortality from suicide and comorbid 19 medical illnesses [1] . Factors reported to be associated with 20 morbidity and disability in mood disorders include symptomatic 21 severity in acute episodes, more recurrences and hospitalizations, 22 financial and legal problems, co-occurring anxiety disorders, and 23 delay of or nonadherence to treatment [2] [3] [4] [5] . Findings from a 24 recent meta-analysis involving 25 studies indicated similarly high 25 levels of long-term morbidity .2] of months ill/ 26 time at risk, overall) in clinically treated bipolar disorder (BD-I, BD-27 II) and major depressive disorder (MDD) patients [1] . Notably, in 28 BD subjects, 70%-80% of this unresolved morbidity was depressive 29 (31% in BD-I, 36% in BD-II), whereas mania-like morbidity, 30 averaged much less among BD-I (10%) and BD-II (6%) subjects Conclusions: Long-term depressive greatly exceeded mania-like morbidity in BD patients. BD-II subjects spent 42% more time ill overall, with a 3.7-times greater D/M morbidity ratio, than BD-I. More time depressed was predicted by agitated/psychotic initial depressive episodes, psychiatric comorbidity, and BD-II diagnosis. Longer prodrome and any antecedent psychiatric syndrome were respectively associated with total and depressive morbidity.
C 2017 Elsevier Masson SAS. All rights reserved. records in random order among those of subjects with a final DSM-90 IV-TR diagnosis of BD (type I or II). Study subjects were drawn at 91 alphabetically from a total of approximately 1000 bipolar patients 92 evaluated and followed by Dr. Koukopoulos for at least one year. 93
Records had to include details of family history, past history,
